Silicon, a material for anode materials, is emerging as a “game changer” that will significantly increase driving ranges on a single charge or shorten charging time.According to the secondary battery material industry on Aug. 16, leading Korean companies such as SK, LG, and POSCO have begun preempti
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that its board of directors has decided to make an equity investment in Novavax, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, securi
The Federation of Korean Industries (FKI) has selected Ryu Jin (65), the Chairman of the Poongsan Group, as its next chairman.According to a press release issued on Aug. 6, the FKI stated, “At the upcoming extraordinary general meeting on Aug. 22, the FKI is planning to change the organization’s nam
After their head-to-head competition in a next-generation naval escort ship contract, HD Hyundai Heavy Industries (HHI) and Hanwha Ocean are shifting their focus. There’s keen interest about whether they will work together to win tens of trillions of won of submarine procurement projects.According t
The trend of collaborations between domestic and foreign enterprises of various sizes to achieve success in new drug development is on the rise. Such collaborations are viewed within the industry as a potential model for “Korean-style Open Innovation” in the pharmaceutical and biotech sectors.Accord
Companies investing in biopharmaceutical-related technologies and production facilities will now be eligible for a maximum tax deduction of 35 percent.On July 27, the Ministry of Economy and Finance held the 56th session of the Tax System Advancement Review Committee presided over by Deputy Prime Mi
The export status to Australia of Hanwha Aerospace’s Infantry Fighting Vehicle (IFV), the Redback, is expected to be announced within a few days. When it was tendered in 2018, the project’s scale was 450 armored vehicles (approximately 16 to 24 trillion won), but due to the change of the Australian
CJ Bioscience announced on July 25 that it has confirmed a total of 15 microbiome drug pipelines, setting the record for the highest number globally among microbiome drug development companies.In March, CJ Bioscience commenced pipeline analysis work after acquiring promising drug candidates from 4D
Korea Development Bank (KDB) is set to start the process of selling its controlling stake in HMM, a deal that is anticipated to be one of the largest M&A transactions in the market, possibly worth up to 5 trillion won.KDB Bank announced on July 20 that they have issued a public competitive bid for t
The author is an analyst for Shinhan Securities. He can be reached at jaewonjeong@shinhan.com -- Ed.2Q23 preview: Earnings to come in line with market expectationsWe now expect GC Biopharma to post consolidated sales of KRW437.1bn (+3.3% YoY) and operating profit of KRW20.3bn (+55.2% YoY, operating
The long-awaited process of selling HMM, considered a major player in the merger and acquisition (M&A) market with an estimated value of up to 5 trillion won (US$3.91 billion), has officially commenced.On July 20, the Industrial Bank of Korea (IBK) and the Korea Ocean Business Corporation (KOBC) iss
Both domestic and global information technology (IT) giants are now joining pharmaceutical and biotech companies in utilizing artificial intelligence (AI) for drug development. Some AI drug development firms are currently in the process of going public through initial public offerings (IPOs).Accordi
JW Pharmaceutical announced on July 20 that it has obtained a patent for the Wnt target hair loss treatment JW0061 from the Australian Patent Office.This patent is related to a new drug candidate for hair loss treatment based on the Wnt signaling pathway and aims to protect “a new heterocyclic induc
Chey Tae-won, chairman of the Korea Chamber of Commerce and Industry (KCCI) and chairman of SK Group, hinted at the possibility of SK Group’s return to the Federation of Korean Industries (FKI).“We hope that the FKI will become a successful organization and we will help the FKI if we can,” Chey said
The Ministry of Trade, Industry and Energy (MOTIE) plans to form a “One Team” with major corporations including SK and GS Energy to drive the small modular reactor (SMR) industry. They aim to establish concrete measures for the revitalization of the SMR industry within this year.According to MOTIE o
Nine merger and acquisition (M&A) deals worth more than US$1 billion were made in the global pharmaceutical and bio industries in the first half of this year.According to the Korea Biotechnology Industry Organization (KBIO) on July 2, the global pharmaceutical and bio industries recorded nine M&A de
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, ‘GBP410’ (also known as SP0202), evaluating i
SK biopharmaceuticals has received Canadian market approval for its newly developed cenobamate epilepsy drug sold under the local product name Xcopri.On June 14, SK biopharmaceuticals announced that Health Canada had issued a Notice of Compliance for cenobamate, approving its application for market
The construction of the Shin Hanul 3 and 4 reactors will begin soon after its cancellation under the previous Moon Jae-in administration.The Korean Ministry of Trade, Industry and Energy held a meeting at the Sejong Government Office on June 12 to deliberate on and resolve the approval of an impleme
Korea’s stock market has been removed from the MSCI Developed Markets Indexes’ watch list of candidates for inclusion in the index. The country’s hopes for inclusion in the indexes have been marking time for nine years.On June 11, MSCI classified South Korea as an emerging market as it released its